WS #10273

16:56→17:22 UTC
From 499 msgs · 3 key-dev

AbbVie reportedly in talks to buy a biotech for $10.9B for an experimental eczema drug, potentially moving ABBV and target.

AbbVie Biotech Acquisition Talks

AbbVie reportedly in talks to buy a biotech for $10.9B for an experimental eczema drug, potentially moving ABBV and target.

Full world state #10273 →

Strait of Hormuz Closure EscalationAnthropic No Longer National Security ThreatTrump-Meloni Diplomatic Spat
← WS #10272WS #10274 →
BearishNegativeNeutralPositiveBullish|ORDER: SIZE ▾↻ RESHUFFLE▸ LATER / NOW|